CLINICAL_TRIALS
trial_result
· 2023-10-10
Clinical Trial Update: rhBNP in Type 3 Pulmonary Hypertension [Phase 4]
Summary
Clinical trial update for recombinant human B-type natriuretic peptide (rhBNP) in Group 3 pulmonary hypertension (Phase 4).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shengjing Hospital | Conditions: Group 3 Pulmonary Hypertension | Phase 4 | Status: UNKNOWN